Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
2.
Sex Transm Dis ; 45(1): 8-13, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-29240633

RESUMO

BACKGROUND: Men who have sex with men with HIV have high sexually transmitted infection (STI) incidence. Thus, the Centers for Disease Control and Prevention (CDC) recommends at least yearly STI screening of HIV-infected individuals. METHODS: We calculated testing rates for syphilis, chlamydia, and gonorrhea among HIV-positive Californians with Medicare or Medicaid insurance in 2010. Logistic regressions estimated how testing for each bacterial STI relates to demographic and provider factors. RESULTS: Fewer than two-thirds of HIV-positive Medicare and fewer than three-quarters of Medicaid enrollees received a syphilis test in 2010. Screenings for chlamydia or gonorrhea were less frequent: approximately 30% of Medicare enrollees were tested for chlamydia or gonorrhea in 2010, but higher proportions of Medicaid enrollees were tested (45%-46%). Only 34% of HIV-positive Medicare enrollees who were tested for syphilis were also screened for chlamydia or gonorrhea on the same day. Nearly half of Medicaid enrollees were tested for all 3 STIs on the same day. Patients whose providers had more HIV experience had higher STI testing rates. CONCLUSIONS: Testing rates for chlamydia and gonorrhea infection are low, despite the increase in these infections among people living with HIV and their close association with HIV transmission. Interventions to increase STI testing include the following: prompts in the medical record to routinely conduct syphilis testing on blood drawn for viral load monitoring, opt-out consent for STI testing, and provider education about the clinical importance of STIs among HIV-positive patients. Last, it is crucial to change financial incentives that discourage nucleic acid amplification testing for rectal chlamydia and gonorrhea infections.


Assuntos
Atenção à Saúde/normas , Fidelidade a Diretrizes , Infecções por HIV/diagnóstico , Medicaid , Medicare , Vigilância em Saúde Pública , Doenças Bacterianas Sexualmente Transmissíveis/diagnóstico , Adulto , California/epidemiologia , Feminino , Guias como Assunto , Infecções por HIV/epidemiologia , Infecções por HIV/terapia , Humanos , Incidência , Masculino , Programas de Rastreamento , Pessoa de Meia-Idade , Razão de Chances , Parceiros Sexuais , Doenças Bacterianas Sexualmente Transmissíveis/prevenção & controle , Doenças Bacterianas Sexualmente Transmissíveis/terapia , Estados Unidos , Carga Viral , Adulto Jovem
4.
Urologiia ; (3): 33-8, 2015.
Artigo em Russo | MEDLINE | ID: mdl-26390557

RESUMO

The aim of the study was to establish the clinical and morphological characteristics of female urethral polyps including cases with concomitant sexually transmitted infections. A total of 150 women were enrolled in the study. The evaluation of microcirculatory changes, morphological parameters and immunogram indices of urethral polyps were carried out. The most common infectious agent in patients with urethral polyps was Ureaplasma urealyticum. In those cases predominance of inflammatory symptoms and elevated levels of serum proinflammatory cytokines were identified. It is found that the pronounced inflammatory reaction leads to an increase in the relative area of the subepithelial microvascular bed and the cellular elements population of lamina mucosa propria, as well as to the relative predominance of congestive forms of microcirculation disturbances according to the laser Doppler flowmetry.


Assuntos
Pólipos/patologia , Doenças Bacterianas Sexualmente Transmissíveis/patologia , Infecções por Ureaplasma/patologia , Doenças Uretrais/patologia , Adulto , Citocinas/sangue , Citocinas/imunologia , Feminino , Humanos , Fluxometria por Laser-Doppler , Microcirculação , Pessoa de Meia-Idade , Pólipos/microbiologia , Pólipos/fisiopatologia , Pólipos/terapia , Doenças Bacterianas Sexualmente Transmissíveis/microbiologia , Doenças Bacterianas Sexualmente Transmissíveis/fisiopatologia , Doenças Bacterianas Sexualmente Transmissíveis/terapia , Infecções por Ureaplasma/microbiologia , Infecções por Ureaplasma/fisiopatologia , Infecções por Ureaplasma/terapia , Ureaplasma urealyticum/isolamento & purificação , Doenças Uretrais/microbiologia , Doenças Uretrais/fisiopatologia , Doenças Uretrais/terapia
5.
Z Gastroenterol ; 52(12): 1408-12, 2014 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-25474280

RESUMO

Two cases of symptomatic proctitis with rectal tumors suspicious for malignancy are presented. A florid regenerative proctitis was shown in the histological examination. In both cases a sexually transmitted infection (STI) was causing the symptoms. In rare cases STIs present as pseudo tumors mimicking malignancy in clinical examination and endoscopic/radiological analysis. A close collaboration between gastroenterologist and pathologist is necessary for a correct diagnosis and to prevent unnecessary surgical treatment.


Assuntos
Neoplasias Retais/etiologia , Neoplasias Retais/patologia , Doenças Bacterianas Sexualmente Transmissíveis/complicações , Doenças Bacterianas Sexualmente Transmissíveis/patologia , Adulto , Diagnóstico Diferencial , Humanos , Masculino , Pessoa de Meia-Idade , Lesões Pré-Cancerosas , Neoplasias Retais/terapia , Doenças Bacterianas Sexualmente Transmissíveis/terapia
6.
Rev. Méd. Clín. Condes ; 22(6): 813-824, nov. 2011.
Artigo em Espanhol | LILACS | ID: lil-687043

RESUMO

Las Infecciones de Transmisión Sexual (ITS) son infecciones causadas por diversos agentes (bacterias, virus, parásitos, protozoos, entre otros) y cuyo mecanismo de transmisión es el contacto sexual: genital, oral o anal, condición que les da su principal característica y que tiene implicancias en la prevención, pues se relaciona directamente con el "comportamiento sexual" del ser humano, y por lo tanto, con un acto de decisión personal. Las ITS son "PROBLEMA DE TODOS" en razón de ser Universales, no respetando razas, sexos, edad, cultura, creencias religiosas, situación socioeconómica, etc. Constituyen aún un importante problema de Salud Pública en todo el mundo a pesar de los esfuerzos por controlarlas y eventualmente erradicarlas como ha sucedido con otras enfermedades infecto contagiosas. Las modernas tecnologías usadas en el diagnóstico de laboratorio permiten identificar con mayor eficiencia los agentes causales, y el desarrollo de nuevos antibióticos permiten tratar con mayor eficacia, interrumpiendo así la transmisión.


Sexually Transmitted Infections (STI) are sexually infections caused for many agents (bacterias, virus, parasites, protozoos, etc.) and where the transmission is the sexual contact, vaginal, anal or oral, condition who give them the principal characteristic. And that have very important implicancies in prevention, because is directed related with sexual behaviour of human being and finally with and act of personal decision. The STI are a problem of all, in reason of being universal, without respect of races, sex, age, culture, religious credences, social economical position, etc. Today are an important problem in public health in all the World in spite the efforts for control and eventually erradicate them in the way who has succeded with others infectious diseases. Moderns technologies used in the laboratory diagnosis allow us identified with more eficcacious the agents and the development of new antibiotics will be the key to treat with more eficciency our patients and by this way close the chain of transmission.


Assuntos
Humanos , Doenças Bacterianas Sexualmente Transmissíveis/epidemiologia , Doenças Bacterianas Sexualmente Transmissíveis/terapia , Doenças Virais Sexualmente Transmissíveis/epidemiologia , Doenças Virais Sexualmente Transmissíveis/terapia , Gonorreia/terapia , Herpes Genital/terapia , Sífilis/terapia , Chile/epidemiologia , Sífilis Cutânea , Sífilis Congênita/epidemiologia
7.
Sex Transm Infect ; 87(7): 577-82, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21965470

RESUMO

OBJECTIVES: To assess the feasibility and outcomes of recalling men who have sex with men (MSM) diagnosed as having a bacterial sexually transmitted infection (STI) for re-screening. METHODS: This evaluation was conducted from December 2008 for a 9-month period. MSM diagnosed as having a bacterial STI in that period were offered recall for re-screening 3 months after their diagnosis. Re-screening rates and infection incidence were calculated. Differences in baseline characteristics by re-screening status and factors predictive of infection at re-screening were assessed using the Mann-Whitney test, χ(2) test and logistic regression. RESULTS: Of the 337 MSM diagnosed as having a bacterial STI, 301 were offered recall. Of these, 206 (68.4%) re-screened after 3 months, 30 (10%) declined and the remainder did not re-attend despite giving verbal consent. Compared with those not re-screening, those re-screening were less likely to be HIV positive (p=0.001), but there was no difference in baseline risk behaviours. There were 15 diagnoses of bacterial STIs at re-screening (29 per 100 person-year follow-up (pyfu); 95% CI 14.3 to 43.7) and five new HIV diagnoses of whom three had a negative test at baseline, one tested negative 6 months earlier and one never tested. Among those testing at both time points, the HIV incidence was 8.3 per 100 pyfu (95% CI 0.0 to 17.7). CONCLUSIONS: This evaluation demonstrates a 'recall for re-screening' strategy is feasible in terms of high re-screening rates and incidence of new infections diagnosed. Experimental evidence is needed to assess cost-effectiveness and whether it achieves its aim of reducing transmission of STIs and HIV.


Assuntos
Controle de Doenças Transmissíveis/métodos , Homossexualidade Masculina , Programas de Rastreamento/métodos , Doenças Bacterianas Sexualmente Transmissíveis/diagnóstico , Doenças Bacterianas Sexualmente Transmissíveis/terapia , Adulto , Idoso , Seguimentos , HIV , Infecções por HIV/prevenção & controle , Infecções por HIV/transmissão , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Doenças Bacterianas Sexualmente Transmissíveis/prevenção & controle , Doenças Bacterianas Sexualmente Transmissíveis/transmissão
8.
Urologiia ; (2): 48-52, 2011.
Artigo em Russo | MEDLINE | ID: mdl-21815458

RESUMO

The study is aimed at investigation of efficacy and safety of a combined effect of laser therapy and vibromagnetotherapy in complex treatment of patients with chronic urethroprostatitis in the presence of sexually transmitted infection (STI). A total of 35 males aged 20 to 51 years entered the study. They were divided into 3 groups. Group 1 received standard basic therapy, group 2 received basic and laser therapy, group 3 - basic treatment and laser plus vibromagnetotherapy. Effectiveness of the treatment was assessed by the evidence obtained from clinical, bacteriological, device and functional examinations. The results of the treatments were evaluated after 2 weeks of the follow-up. It is shown that patients of groups 2 and 3 achieved more pronounced improvement of clinical and laboratory indices, parameters of basal blood flow. Thus, physiotherapy, added to antibacterial treatment, is safe and effective in the treatment of chronic urethroprostatitis and STI.


Assuntos
Terapia a Laser/métodos , Magnetoterapia/métodos , Prostatite/terapia , Doenças Bacterianas Sexualmente Transmissíveis/terapia , Uretrite/terapia , Adulto , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Prostatite/complicações , Doenças Bacterianas Sexualmente Transmissíveis/complicações , Uretrite/complicações
9.
Med Wieku Rozwoj ; 9(1): 117-25, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16082073

RESUMO

Worldwide, Chlamydia trachomatis (CT) is the most common sexually transmitted bacteria. The improved understanding of CT pathophysiology in recent years became possible through DNA amplification technique and genome cloning. This paper updates informations on chlamydial infection in pregnant women, its pathophysiology, diagnostic methods, prevention and treatment. There is increasing evidence that Chlamydia trachomatis infection may result in a number of adverse pregnancy outcomes, including early and late abortion, infection of the foetus, stillbirth, premature rupture of membranes, prematurity and postpartum endometritis. Ectopic pregnancy is often associated with a previous tubal chlamydial infection. C. trachomatis infection in newborns may be acquired during pregnancy or during vaginal delivery, and it may result in neonatal conjunctivitis and/or pneumonia. We discuss benefits of early treatment of chlamydial infections in pregnant women and present guidelines for treatment. Screening should lead to early detection and treatment of men and women with chlamydial infection and thereby reduce the incidence of pelvic inflammatory disease, tubal infertility and ectopic pregnancy.


Assuntos
Infecções por Chlamydia/prevenção & controle , Chlamydia trachomatis/isolamento & purificação , Programas de Rastreamento/normas , Doenças Bacterianas Sexualmente Transmissíveis/microbiologia , Doenças Bacterianas Sexualmente Transmissíveis/prevenção & controle , Infecções por Chlamydia/diagnóstico , Infecções por Chlamydia/microbiologia , Infecções por Chlamydia/terapia , Feminino , Humanos , Masculino , Gravidez , Doenças Bacterianas Sexualmente Transmissíveis/terapia
10.
J Obstet Gynaecol Can ; 26(6): 552-9, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15193199

RESUMO

The objective of the review is to alert reproductive-care providers to the unexpected resurgence of Chlamydia infections and to new findings related to complications associated with Chlamydia infection. Data sources consisted of national and local guidelines and literature searches of MEDLINE with the heading Chlamydia infections 2002 and 2003. The complications of Chlamydia infections are considered to be longterm, and may include debilitating pain, infertility, tubal pregnancy, cancer, and HIV infection. Only a strong disease-management response from reproductive-care providers, using new diagnostic techniques and simpler treatment regimens, as well as a strong public health reaction, will be effective to limit the scourges of Chlamydia infection in the female population.


Assuntos
Infecções por Chlamydia , Chlamydia trachomatis/patogenicidade , Canadá , Infecções por Chlamydia/complicações , Infecções por Chlamydia/diagnóstico , Infecções por Chlamydia/terapia , Infecções por Chlamydia/transmissão , Notificação de Doenças , Feminino , Humanos , Masculino , Saúde Pública , Doenças Bacterianas Sexualmente Transmissíveis/complicações , Doenças Bacterianas Sexualmente Transmissíveis/diagnóstico , Doenças Bacterianas Sexualmente Transmissíveis/epidemiologia , Doenças Bacterianas Sexualmente Transmissíveis/terapia
11.
Sex Transm Dis ; 30(8): 654-8, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12897689

RESUMO

BACKGROUND: The persistence of syphilis and other bacterial sexually transmitted diseases (STDs) in many areas of the United States suggests that innovative approaches to controlling these diseases are needed. GOAL: To evaluate the feasibility, acceptability, and yield of mobile community-based STD screening and treatment services in high STD incidence areas. STUDY DESIGN: Free, voluntary, confidential screening and treatment for STDs were conducted in high STD incidence neighborhoods of Baton Rouge, Louisiana, using a 32-foot mobile van. Demographic and behavioral data were obtained from participants. Participants were screened for syphilis, chlamydia, and gonorrhea and were also offered HIV testing. Community attitudes toward the screening program were assessed with street-intercept surveys conducted two weeks after screening events. RESULTS: From March 1997 to August 2000, 256 community-based screening events were held. During this period, 3110 blood samples were collected for syphilis testing, of which 37 (1.2%) new cases of syphilis were identified. Of the 2807 blood samples collected for HIV testing, 70 (2.5%) were positive. Of 2229 urine samples, 185 (8.3%) tested positive for Chlamydia trachomatis and 108 (4.9%) positive for Neisseria gonorrhoeae. Of 389 street-intercept surveys, 97% of respondents thought that neighborhood STD testing was a "good" or "very good" idea. CONCLUSION: Mobile community-based STD screening and treatment are feasible, identify high positivity of STDs, and are accepted by the community as an innovative approach to STD control.


Assuntos
Programas de Rastreamento/estatística & dados numéricos , Unidades Móveis de Saúde/estatística & dados numéricos , Infecções Sexualmente Transmissíveis/diagnóstico , Infecções Sexualmente Transmissíveis/terapia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Infecções por Chlamydia/diagnóstico , Infecções por Chlamydia/prevenção & controle , Estudos Transversais , Estudos de Viabilidade , Feminino , Gonorreia/diagnóstico , Gonorreia/prevenção & controle , Infecções por HIV/diagnóstico , Infecções por HIV/prevenção & controle , Humanos , Louisiana , Masculino , Pessoa de Meia-Idade , Infecções Sexualmente Transmissíveis/prevenção & controle , Doenças Bacterianas Sexualmente Transmissíveis/diagnóstico , Doenças Bacterianas Sexualmente Transmissíveis/prevenção & controle , Doenças Bacterianas Sexualmente Transmissíveis/terapia , Inquéritos e Questionários , Sífilis/diagnóstico , Sífilis/prevenção & controle
12.
Prim Care ; 30(1): 173-91, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12825255

RESUMO

The diagnosis and treatment of STDs is a common problem in primary care practice; however, newer diagnostic and therapeutic alternatives require physicians to be aware of evidence-based guidelines that are continuing to evolve. The treatment of STDs in men, in particular, is an area of evolving evidence because much of what is known is based on the treatment of STDs in women. Men represent unique challenges in diagnosis, evaluation, and follow-up that need to be considered in the treatment of urethritis, epididymitis, herpes genitalis, condyloma, prostatitis, and other syndromes. Screening for asymptomatic STDs is currently not recommended in the general population, but selected criteria can be used to identify a target population for screening in high-risk areas.


Assuntos
Medicina de Família e Comunidade/normas , Doenças Bacterianas Sexualmente Transmissíveis , Doenças Virais Sexualmente Transmissíveis , Infecções por Chlamydia/diagnóstico , Infecções por Chlamydia/microbiologia , Infecções por Chlamydia/terapia , Condiloma Acuminado/diagnóstico , Condiloma Acuminado/microbiologia , Condiloma Acuminado/terapia , Epididimite/diagnóstico , Epididimite/microbiologia , Epididimite/terapia , Herpes Genital/diagnóstico , Herpes Genital/microbiologia , Herpes Genital/terapia , Humanos , Masculino , Educação de Pacientes como Assunto/métodos , Prevenção Primária/métodos , Prostatite/diagnóstico , Prostatite/microbiologia , Prostatite/terapia , Recidiva , Doenças Bacterianas Sexualmente Transmissíveis/diagnóstico , Doenças Bacterianas Sexualmente Transmissíveis/microbiologia , Doenças Bacterianas Sexualmente Transmissíveis/terapia , Doenças Virais Sexualmente Transmissíveis/diagnóstico , Doenças Virais Sexualmente Transmissíveis/microbiologia , Doenças Virais Sexualmente Transmissíveis/terapia , Estados Unidos , Uretrite/diagnóstico , Uretrite/etiologia , Uretrite/terapia
13.
Rev. patol. trop ; 31(1): 1-21, jan.-jun. 2002. tab
Artigo em Português | LILACS | ID: lil-387319

RESUMO

Este trabalho reviu a infecção urogenital por Chlamydia trachomatis, considerada a doença bacteriana sexualmente transmissível mais comum no mundo, especialmente na população de adolescentes e jovens. Grande parte das infecções clamidiais é assintomática, principalmente nas mulheres, e se não tratadas podem causar complicações, como a doença inflamatória pélvica (DIP), com seqüelas como a infertilidade, gravidez ectópica e dor pélvica crônica. Por várias décadas, a cultura foi considerada como o padrão ouro no diagnóstico dessa infecção. Nos últimos anos foram introduzidos os testes de detecção ácidos nucléicos, como a reação em cadeia da polimerase (PCR) e a reação em cadeia da ligase (LCR). Apresentou-se o tratamento recomendado pelo Ministério da Saúde, bem como os princípios da prevenção que incluem a educação sexual, o diagnóstico e tratamento dos casos diagnosticados e de seus parceiros sexuais, abrangendo a proposta de rastreamento nas populações de risco.


Assuntos
Humanos , Masculino , Feminino , Chlamydia trachomatis , Técnicas de Laboratório Clínico , Doenças Bacterianas Sexualmente Transmissíveis/diagnóstico , Doenças Bacterianas Sexualmente Transmissíveis/terapia
14.
Rev Prat ; 52(16): 1763-7, 2002 Oct 15.
Artigo em Francês | MEDLINE | ID: mdl-12564166

RESUMO

The incidence of acute salpingitis which are only one aspect of pelvic inflammatory disease has decreased during the last 20 years and more and more patients have mild symptoms. Consequences of this evolution are uncertainty for the diagnosis without laparoscopic proof of the pelvic inflammatory disease, ambulatory treatment with inappropriate regimen increasing the risk of chronical disease and long term sequelae. So laparoscopy must remain a standard in diagnosis and treatment especially in young childless women. Follow up of the medical treatment is necessary to assess its effectiveness and its compliance, to treat the sexual partner, and to provide informations about preventive measures to avoid relaps.


Assuntos
Infecções por Chlamydia/diagnóstico , Salpingite/diagnóstico , Doenças Bacterianas Sexualmente Transmissíveis/diagnóstico , Infecções por Chlamydia/microbiologia , Infecções por Chlamydia/prevenção & controle , Infecções por Chlamydia/terapia , Diagnóstico Diferencial , Feminino , Seguimentos , Humanos , Laparoscopia/métodos , Salpingite/microbiologia , Salpingite/terapia , Doenças Bacterianas Sexualmente Transmissíveis/microbiologia , Doenças Bacterianas Sexualmente Transmissíveis/terapia
15.
Sex Transm Dis ; 26(9): 496-9, 1999 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10534201

RESUMO

OBJECTIVE: Although testing for Chlamydia trachomatis is encouraged and increasingly practiced at sexually transmitted disease (STD) and family planning clinics, patterns of testing and follow-up in other settings are not well described. To begin to address these issues, we performed a chart review of patients with a positive laboratory test for C. trachomatis at a major university medical center. METHODS: Chart review of medical records for all patients with positive laboratory tests for C. trachomatis during calendar year 1996. RESULTS: Of 326 patients with positive tests, 95% were female and 5% were male. Median age was 22 for females and 25 for males. Most positive C. trachomatis test results were from the emergency room (ER)/walk-in clinic (55%) or patients receiving obstetric/gynecologic (OB/GYN) care (31%). While most C. trachomatis tests performed were on patients who had symptoms, patterns of treatment varied between sites. Fifty-seven percent of ER/walk-in patients received empiric antibiotics at the initial visit versus 36% of patients under OB/GYN care. Among patients with positive screening tests seen in the ER/walk-in clinic, 32% of patients had no treatment documented versus 14% of OB/GYN patients. Four percent of women with positive tests who did not receive therapy at the time of their initial evaluation developed pelvic inflammatory disease in the interval between testing and return to the medical center. CONCLUSIONS: Of the patients with positive chlamydial screening tests, the proportion not treated was similar to that found in studies performed in STD clinics.


PIP: A chart review of patients with positive laboratory tests for C. trachomatis at the University of Alabama at Birmingham Hospital and affiliated clinics during 1996 was performed to determine whether the problem of failure to notify patients of positive sexually transmitted disease (STD) test results is generalizable beyond STD clinics. Furthermore, it would review chlamydia testing practices in nonreproductive health setting. Findings revealed that of the 326 patients with positive tests, 95% were females aged 22 years and 5% were males aged 25 years. Most positive C. trachomatis test results were 51% from the emergency room (ER) and 31% from obstetric/gynecologic (OB/GYN). 57% of ER patients and 36% of OB/GYN patients received antibiotics on their initial visits. Among patients with positive screening tests, 32% of ER patients and 14% of OB/GYN patient had no documented treatment. 4% of women with positive tests, who did not receive therapy at the time of their initial evaluation, developed pelvic inflammatory disease in the interval between testing and returning to the medical center. From the findings, a substantial proportion of patients with positive screening tests for C. trachomatis may not receive timely treatment of their infections, which suggests that the problem occurs in settings other than STD and family clinics.


Assuntos
Infecções por Chlamydia/diagnóstico , Adulto , Alabama , Antibacterianos/uso terapêutico , Infecções por Chlamydia/microbiologia , Infecções por Chlamydia/terapia , Chlamydia trachomatis/isolamento & purificação , Busca de Comunicante/estatística & dados numéricos , Feminino , Hospitais Universitários , Humanos , Masculino , Programas de Rastreamento , Prevalência , Fatores Sexuais , Doenças Bacterianas Sexualmente Transmissíveis/diagnóstico , Doenças Bacterianas Sexualmente Transmissíveis/microbiologia , Doenças Bacterianas Sexualmente Transmissíveis/terapia
19.
Orv Hetil ; 130(24): 1259-62, 1989 Jun 11.
Artigo em Húngaro | MEDLINE | ID: mdl-2671855

RESUMO

The authors report on their experiences gained at the sexually transmitted disease clinic they established at the First Department of Obstetrics and Gynecology of Semmelweis Medical University. A total of 456 patients presenting with signs and symptoms of lower genital tract infection have been examined in one year. The investigation of patients included aerobic and anaerobic culture of vaginal bacteria, vaginal smear and the identification of sexually transmitted Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasmatales and Gardnerella vaginalis. The authors conclude that a sexually transmitted disease clinic is appropriate to contribute to the prevention of horizontal and vertical spread of the sexually transmitted bacterial infections.


Assuntos
Instituições de Assistência Ambulatorial , Doenças dos Genitais Femininos/diagnóstico , Doenças Bacterianas Sexualmente Transmissíveis/diagnóstico , Feminino , Doenças dos Genitais Femininos/microbiologia , Doenças dos Genitais Femininos/terapia , Humanos , Hungria , Programas de Rastreamento , Doenças Bacterianas Sexualmente Transmissíveis/microbiologia , Doenças Bacterianas Sexualmente Transmissíveis/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA